170602 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.) transferring one-carbon groups (2.1); Methyltransferases (general) (2.1.1.) with definite EC number (2.1.1.-)
Sub-classes:METHOD TO DISTINGUISH ASPARTATE FROM ISOASPARTATE IN A PROTEIN
#2MICROENVIRONMENTAL DETERMINANTS OF CLONAL HEMATOPOIESIS EXPANSION RATE
#3EX VIVO COLONIC BIOPSY PLATFORM TO EVALUATE MULTI-OMIC SIGNATURES FOR SCREENING CANDIDATE THERAPEUTICS
#4USE OF SET7/9 FOR DIAGNOSING AND TREATING ENDMT-RELATED DISEASE
#5METHODS FOR PREDICTING DRUG RESPONSIVENESS IN HEART FAILURE SUBJECTS
#6Biomarkers of Marine Invertebrate Stress
#7KMT2A-MAML2 FUSION MOLECULES AND USES THEREOF
#8Biomarker composition for predicting cancer malignant prognosis induced by microplastic exposure
#9DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT
#10Fusion proteins for the detection of apoptosis
#11Clonal haematopoiesis
#12Methods of detecting modified and unmodified DNA
#13MOLECULAR PROFILING FOR CANCER
#14Method for treating and prognosing cancer
#15Quantifying MGMT Protein For Optimal Cancer Therapy
#16INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
#17Quantifying MGMT protein for optimal cancer therapy of glioblastoma
#18Methods of treating cancer
#19METHODS FOR TREATING CANCER
#20SRM/MRM Assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein
#21Process for in vitro diagnosis of hepatic disorders
#22INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
#23Method for treating and prognosing cancer
#24Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy
#25Substituted purine compounds
#26MOLECULAR PROFILING FOR CANCER
#27Substituted indoles
#28METHODS OF TREATING CANCER
#29Clonal haematopoiesis
#30EPIGENETIC COMPOUND SCREENING PLATFORM
#31Substituted Indoles
#32CHROMATIN-ACTIVITY-BASED CHEMOPROTEOMIC (CHAC) METHODS AND SYSTEMS FOR DISEASE MARKER DISCOVERY AND DEVELOPMENT
#33Pharmaceutical composition for treating chronic kidney disease
#34INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
#35Substituted purine compounds
#36METHODS OF TREATING CANCER PATIENTS RESPONDING TO EZH2 INHIBITOR GSK126
#37SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein
#38cell line with thyA knockout, folA knockout, and one or both of folP knockout, and folK knockout
#39DIAGNOSTIC IN VITRO METHOD
#40DOT1L probes
#41Se-Adenosyl-L-Selenohomocysteine Selenoxide As A Modulator Of Methyltransferase And Other Activities
#42Homogenous thermal shift ligand binding assay
#43MARKERS FOR ACUTE LYMPHOBLASTIC LEUKEMIA
#44Method of treatment of SETDB1 expressing cancer
#45Compositions and methods for detecting and treating colorectal cancer
#46METHODS FOR IDENTIFYING AND INHIBITING GROWTH OF CHEMOTHERAPEUTIC-RESISTANT CANCERS
#47GAS BIOSENSORS
#48Method for detecting injury to the brain
#49Methods of treating cancer
#50Epigenetic co-repressors of the gamma-globin gene and methods of using same
#51Inhibitors of human EZH2, and methods of use thereof
#52Compositions for Inhibiting Growth of Cancer Stem Cells
#53Method for predicting therapeutic effect of chemotherapy on renal cell cancer
#54Diagnosis and treatment of cancer
#55METHODS OF AIDING IN THE DIAGNOSIS OF PROSTATE CANCER
#56Diagnostic composition and kit for renal cell carcinoma
#57SMALL MOLECULE INHIBITORS OF BACTERIAL DAM DNA METHYLTRANSFERASES
#58TREATMENT METHODS
#59Treatment methods
#60Methods of treating cancer